Gene: PRELID3A
Official Full Name: PRELI domain containing 3Aprovided by HGNC
Gene Summary: Enables phosphatidic acid transfer activity. Involved in phospholipid transport. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31644 | PRELID3A Knockout cell line (HeLa) | Human | PRELID3A | 1:3~1:6 | Negative | Online Inquiry |
KO31645 | PRELID3A Knockout cell line (HCT 116) | Human | PRELID3A | 1:2~1:4 | Negative | Online Inquiry |
KO31646 | PRELID3A Knockout cell line (HEK293) | Human | PRELID3A | 1:3~1:6 | Negative | Online Inquiry |
KO31647 | PRELID3A Knockout cell line (A549) | Human | PRELID3A | 1:3~1:4 | Negative | Online Inquiry |
PRELID3A Gene Knockout Cell Lines represent a significant advancement in gene editing technology, specifically designed to facilitate the in-depth study of PRELID3A, a critical gene implicated in cellular processes such as lipid metabolism and mitochondrial function. Utilizing the CRISPR-Cas9 gene-editing system, these knockout cell lines provide a precise and efficient means to create loss-of-function models, allowing researchers to elucidate the biological role of PRELID3A within various cellular contexts.
The primary function of PRELID3A Gene Knockout Cell Lines lies in their ability to enable researchers to investigate the contribution of PRELID3A in pathophysiological conditions. By selectively knocking out this gene, scientists can observe the resultant phenotypic changes, assess metabolic shifts, and explore the underlying molecular mechanisms. This model is invaluable for studies examining metabolic disorders, neurodegeneration, and cancer biology, where understanding the specific functions of genes can lead to the identification of potential therapeutic targets.
One of the critical advantages of using PRELID3A Gene Knockout Cell Lines is their specificity and scalability. Unlike traditional methods, such as RNA interference, which may produce off-target effects or incomplete knockdown, the CRISPR-Cas9 system offers a more robust and reliable gene edition, ensuring complete knockout of PRELID3A. Furthermore, the ease of use and rapid generation of knockout lines enable high-throughput screening and facilitate timely experimental workflows.
Researchers and clinicians will find these cell lines invaluable as they confront the challenges posed by diseases associated with metabolic dysregulation. With a strong foundation in cutting-edge genomic techniques, our company is positioned as a leader in providing innovative biological products that empower the scientific community to push the boundaries of discovery. PRELID3A Gene Knockout Cell Lines exemplify our commitment to quality and excellence, ultimately supporting your research goals and advancements in precision medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.